AB1250 Vaccination awareness and uptake in inflammatory arthritis patients. (12th June 2018) - Murray, K.
Abstract : Background: Inflammatory arthritides (IA) increase infection risk. The Centre for Disease Control and Prevention recommends influenza vaccination for all adults and pneumococcal vaccine for >65 years old and under 64 years receiving certain immunosuppressive therapies, including TNF inhibitors. Objectives: We examined patients' knowledge, uptake and attitudes to influenza and pneumococcal vaccination and opportunities to increase vaccination rates in our IA clinic. Methods: Patients attending the IA Clinic completed an anonymous 23 question worksheet recording demographic details, medical history, medications, knowledge about vaccinations, vaccination status, reasons for non-vaccination and availability and willingness to use smartphone for healthcare records. Results: 329 patients completed the survey. Respondents were predominantly female (78%). 69% were >50 years old. 82% had completed secondary education. 59% of patients had rheumatoid arthritis, 11% had psoriatic arthritis and 30% other conditions. 29% of patients were taking a biological DMARD, 27% using methotrexate and 19% oral steroids. 52% knew some rheumatological conditions increase infection risk. 54% knew some rheumatological medications can increase infection risk. 66% knew influenza vaccination was recommended, most commonly via their general physician (GP) (70%). 50% of patients were up to date with their 'flu' vaccination, mainly (75%) via their GP. Reasons for non-vaccination included lack of awareness (45%) and fear of side effects (25%). 29% knew pneumococcal vaccination may be indicated, 78% of whom were informed by their GP. 33% of patients were up to date with their pneumococcal vaccine. 80% cited lack of awareness for non-vaccination. 70% of patients had smart phone access. 74% of these were willing to use this for their healthcare record and reminders re vaccination. Conclusions: These data show low awareness amongst IA patients of the risk of immunosuppression associated with their disease and treatments and the need for regular vaccinations. Mobile technology may help increase vaccination rates. Disclosure of Interest: None declared